Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK4/6-IN-3 is a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM) used for the treatment of glioblastoma. It inhibits CDK1 with a Ki of 110 nM.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 624,500 |
50 mg | 約10-14 週間 | ¥ 822,000 |
100 mg | 約10-14 週間 | ¥ 1,124,500 |
説明 | CDK4/6-IN-3 is a brain-penetrant CDK4/CDK6 inhibitor (Kis: <0.3 nM and 2.2 nM) used for the treatment of glioblastoma. It inhibits CDK1 with a Ki of 110 nM. |
ターゲット&IC50 | CDK1:110 nM (ki), CDK4:0.3 nM (ki), CDK6:2.2 nM (ki) |
分子量 | 462.57 |
分子式 | C25H31FN8 |
CAS No. | 2366237-37-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK4/6-IN-3 2366237-37-6 Cell Cycle/Checkpoint CDK CDK4/6 IN 3 CDK-4/6-IN-3 CDK4/6IN3 Inhibitor inhibitor inhibit